Latest Active Biotech News & Updates

See the latest news and media coverage for Active Biotech. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Active Biotech

Biotech company developing cancer and eye disease treatments

activebiotech.com
Headquarters
Lund, Sweden
Founded year
1998
Company type
Public company
Number of employees
2–20

Last updated

Latest news about Active Biotech

In short: Active Biotech implemented a reverse share split, resumed its clinical recruitment for tasquinimod, and reported improved financial performance.

Company announcements

Active Biotech

Active Biotech holds its Annual General Meeting

The Meeting approved a 1:100 reverse share split, no dividend for 2025, re-elected board members, authorized share issues up to 30%, and amended the Articles' share limits.

Active Biotech

Active Biotech publishes LION study results

The phase I study shows topical laquinimod penetrates the eye's posterior segment, is well-tolerated, supporting development for inflammatory eye diseases.

Unlock all announcements with a

Media coverage

FinanzNachrichten

Active Biotech AB: Active Biotech Interim Report Q1 2026

EVENTS DURING THE FIRST QUARTERThe US Patent Office (US PTO) granted a patent related to a pharmaceutical formulation of tasquinimod (January)Active Biotech receives positive feedback...

Unlock all articles with a

Never miss news about Active Biotech

Track Active Biotech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Active Biotech competitors & trending companies

Browse news for competitors to Active Biotech and other trending companies.